Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
alnylam pharmaceuticals
harvard pilgrim health care
institute for clinical and economic review
new york blog main
akcea therapeutics
amy schulman
andreas klein
anna greka
barry greene
biopharma
biotech
car-t
caron jacobson
cigall kadoch
craig mello
dan ollendorf
deals
drugs
duchenne
europe blog main
europe top stories
european medicines agency
events
fda
foghorn therapeutics
gene therapy
goldfinch biopharma
hereditary transthyretin amyloidosis
inotersen
licensing
luxturna
m&a
michael sherman
muscular dystrophy
What
gene
3
×
rna
3
×
fda
interference
medicine
therapy
alnylam
approval
approves
aren’t
betting
billion
biopharma
car
cells
cutting
deal
drug
duchenne
edge
ema
employ
europe
experiments
follows
harmful
historic
hits
hot
launch
make
market
medicines
method
mute
payers
photos
protein
puts
real
Language
unset
Current search:
gene
×
boston
×
rna
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”